Brain Metastases
📧 Sign up to get email alerts when something new happens for Brain Metastases.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-01-26Clinical Trial Update: Hippocampal-Avoiding Whole Brain Irradiation With Simultaneous Integrated Boost for Treatment of Brain Metastases [Phase 2]
A Phase 2 trial evaluating hippocampal-avoiding whole brain irradiation with a simultaneous integrated boost for brain metastases has comple…
-
CLINICAL_TRIALS trial_result · 2021-01-05Clinical Trial Update: Central Nervous System(CNS) Efficacy of Dacomitinib [Phase 2]
Phase 2 trial update assessing CNS efficacy of dacomitinib in non-small cell lung cancer with brain metastases.
-
CLINICAL_TRIALS trial_result · 2020-11-25Clinical Trial Update: A Phase II Trial of Upfront Radiotherapy Plus Almonertinib for Epidermal Growth Factor Receptor(EGFR)-Mutant Non-small-cell Lung Cancer(NSCLC) Patients With Brain Metastases [Phase 2]
A Phase II trial evaluating upfront radiotherapy plus almonertinib for EGFR-mutant non-small cell lung cancer with brain metastases.
-
CLINICAL_TRIALS trial_result · 2020-11-20Clinical Trial Update: Pyrotinib, Trastuzumab And Abraxane in HER2-positive MBC With Brain Metastasis [Phase 2]
Phase 2 trial update involving pyrotinib, trastuzumab, and Abraxane for HER2-positive metastatic breast cancer with brain metastases.
-
CLINICAL_TRIALS trial_result · 2020-10-30Clinical Trial Update: Radiation Therapy With or Without Thalidomide in Treating Patients With Brain Metastases [Phase 3]
A Phase 3 trial evaluating radiation therapy with or without thalidomide for brain metastases has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-10-22Clinical Trial Update: Melatonin and Radiation Therapy in Treating Patients With Brain Metastases [Phase 2]
A Phase 2 clinical trial evaluating melatonin in combination with radiation therapy for brain metastases has been completed.
-
CLINICAL_TRIALS trial_result · 2020-09-16Clinical Trial Update: Trial of Cabozantinib (XL184) in Non-Small Cell Lung Cancer With Brain Metastases [Phase 2]
Phase 2 trial of cabozantinib in non-small cell lung cancer with brain metastases was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2020-08-03Clinical Trial Update: Temozolomide in Treating Patients With Solid Tumors That Have Spread to the Brain [Phase 2]
Phase 2 trial evaluating temozolomide in patients with solid tumors that have metastasized to the brain has completed.
-
CLINICAL_TRIALS trial_result · 2020-07-27Clinical Trial Update: Stereotactic Radiation Therapy in Treating Patients With Brain Metastases [Phase 2]
Phase 2 clinical trial update evaluating stereotactic radiation therapy for patients with brain metastases has completed.
-
CLINICAL_TRIALS trial_result · 2020-06-04Clinical Trial Update: X-396 (Ensartinib) Capsules in ALK-Positive NSCLC Patients With Brain Metastases [Phase 2]
Phase 2 trial update for X-396 (Ensartinib) capsules in ALK-positive non-small cell lung cancer with brain metastases.
-
CLINICAL_TRIALS trial_result · 2020-05-12Clinical Trial Update: A Study of HER2+ Breast Cancer Patients With Active Brain Metastases Treated With Afatinib & T-DM1 vs. T-DM1 Alone [Phase 2]
Phase 2 trial evaluating afatinib plus T-DM1 versus T-DM1 alone in HER2-positive breast cancer with active brain metastases.
-
CLINICAL_TRIALS trial_result · 2020-04-22Clinical Trial Update: Nitroglycerin Plus Intracranial Radiotherapy for Brain Metastases in NSCLC Patients [Phase 2]
Phase 2 clinical trial evaluating nitroglycerin plus intracranial radiotherapy versus radiotherapy alone in NSCLC patients with brain metast…
-
CLINICAL_TRIALS trial_result · 2020-04-09Clinical Trial Update: An Open Label, Multicenter, Phase II Study of Dacomitinib for EGFR Mutated Non-Small Cell Lung Cancer (NSCLC) With Brain Metastases [Phase 2]
Phase II open-label study investigating dacomitinib for EGFR-mutated non-small cell lung cancer with brain metastases.
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: Analysis of Gut Microbiota in Patients With Brain Metastasis of Non-small Cell Lung Cancer Treated by Pembrolizumab Combined With Chemotherapy [Phase 1, Phase 2]
Phase 1/2 trial update examining how gut microbiota relates to outcomes in brain metastasis from non-small cell lung cancer treated with pem…
-
CLINICAL_TRIALS trial_result · 2020-03-06Clinical Trial Update: Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain Metastases [Phase 3]
Phase 3 trial evaluating memantine hydrochloride with whole-brain radiotherapy (with or without hippocampal avoidance) to reduce neurocognit…
-
CLINICAL_TRIALS trial_result · 2020-03-05Clinical Trial Update: Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases [Phase 2]
Phase 2 trial investigating pemetrexed disodium for recurrent malignant gliomas, primary CNS lymphoma, or brain metastases; status is unknow…
-
CLINICAL_TRIALS trial_result · 2020-03-04Clinical Trial Update: Stereotactic Radiosurgery Combination With Anlotinib for Limited Brain Metastases With Perilesional Edema in NSCLC [Phase 2]
Phase 2 trial update investigating stereotactic radiosurgery with anlotinib for limited brain metastases in NSCLC with perilesional edema.
-
CLINICAL_TRIALS trial_result · 2020-03-03Clinical Trial Update: Treatment of Brain Metastases From Breast Cancer With Eribulin Mesylate [Phase 2]
Phase 2 clinical trial evaluating eribulin mesylate for brain metastases from metastatic breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-02-25Clinical Trial Update: ANG1005 in Breast Cancer Patients With Recurrent Brain Metastases [Phase 2]
Phase 2 trial update for ANG1005 in patients with breast cancer and brain metastases.
-
CLINICAL_TRIALS trial_result · 2019-12-30Clinical Trial Update: Sintilimab Combined With Bevacizumab for Brain Metastases From Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating sintilimab in combination with bevacizumab for brain metastases in non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2019-12-12Clinical Trial Update: Lapatinib for Brain Metastases In ErbB2-Positive Breast Cancer [Phase 2]
Phase 2 trial update of lapatinib for brain metastases in ErbB2-positive breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-12-10Clinical Trial Update: The Role of Brain Radiotherapy in Patients With Asymptomatic Brain Metastasis in the Era of Targeted Therapy for NSCLC [Phase 2]
A Phase 2 clinical trial evaluating the role of brain radiotherapy in asymptomatic brain metastases in non-small cell lung cancer patients u…
-
CLINICAL_TRIALS trial_result · 2019-11-27Clinical Trial Update: SRS Sequential Sindilimab in Brain Metastasis of NSLSC [Phase 2]
Phase 2 trial update for sequential sintilimab (SRS) in brain metastases from NSCLC.
-
CLINICAL_TRIALS trial_result · 2019-11-27Clinical Trial Update: Dexamethasone for Palliation - Brain Metastases [Phase 2]
Phase 2 trial update evaluating dexamethasone for palliation in brain metastases has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-13Clinical Trial Update: Efficacy of metfOrmin in PrevenTIng Glucocorticoid-induced Diabetes in Patients With Brain Metastases [Phase 2]
Phase 2 trial evaluating metformin for preventing glucocorticoid-induced diabetes in patients with brain metastases, with melanoma context.